EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beyond Tumor Immunity: The Disruption of Endocrine and Infectious Homeostasis by Immune Checkpoint Inhibitors

Ema Schönberger iD, Luka Švitek iD, Barbara Grubišić iD, Tara Cvijić Perić iD, Romana Marušić iD, Nika Vlahović Vlašić iD, Tomislav Kizivat iD, Silvija Canecki Varžić iD, Lorna Stemberger Marić iD, Ines Bilić Ćurčić iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262311619 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ema Schönberger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Internal Medicine Clinic, University Hospital Centre Osijek, 31000 Osijek, Croatia. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms, Homeostasis, Endocrine System Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine Osijek, located at J. Huttlera 4, 31000 Osijek, Croatia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by reactivating T cell-mediated anti-tumor immunity. However, this enhanced immune activity can lead to immune-related adverse events (irAEs). This narrative review focuses on endocrine irAEs, including thyroid dysfunction, hypophysitis, adrenal insufficiency, and diabetes mellitus. It also explores infectious complications and their underlying mechanisms. These mechanisms include immune dysregulation resulting directly from ICI-induced T-cell activation and indirectly from the immunosuppressive therapies used to treat irAEs. Furthermore, potential role of endocrine irAEs in predisposing patients to infectious complications is analyzed. The objective is to provide non-oncology specialists with the clinical insight necessary to recognize and manage these complex side effects. This narrative review synthesizes current literature on the diagnosis, management, and pathophysiology of endocrine irAEs and infections associated with different classes of ICIs (anti-CTLA-4, anti-PD-1, and anti-PD-L1). Endocrine irAEs are common, with incidence varying by ICI type; combination therapies pose the highest risk. Thyroid dysfunction is the most frequent, followed by hypophysitis, which often leads to permanent secondary adrenal insufficiency. ICI-induced diabetes mellitus is a rare but serious complication, frequently presenting as diabetic ketoacidosis. ICIs are believed to induce a distinct array of infections resulting from immunological dysregulation, unrelated to immunosuppressive medication. The phenomenon is increasingly called ICI therapy-induced dysregulated immunity. Moreover, evidence suggests that endocrine irAEs can compromise immune function and lead to a significantly higher risk of bacterial and fungal infections. Identifying infections that imitate irAEs is particularly important because the therapy is significantly distinct. Greater interdisciplinary awareness is crucial for the early recognition and appropriate management of both the endocrine and infectious complications, ultimately improving the safety and outcomes for patients receiving immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasmsHomeostasisEndocrine System DiseasesInfectionsHumansAdrenal InsufficiencyHypophysitisDiabetes Mellitus

Stichwörter der Autor:innen

endocrine dysfunctionimmune checkpoint inhibitorsimmune-related adverse effectsinfections

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Endocrinology, Internal Medicine Clinic, University Hospital Centre Osijek, 31000 Osijek, Croatia.
  • Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, 31000 Osijek, Croatia.
  • Department of Medical Microbiology and Infectious Diseases, Faculty of Medicine Osijek, J. J. Strossmayer University of Osijek, 31000 Osijek, Croatia.
  • Clinic of Infectious Diseases, University Hospital Centre Osijek, 31000 Osijek, Croatia.
  • Clinic of Oncology, University Hospital Centre Osijek, 31000 Osijek, Croatia.
  • National Memorial Hospital "Dr. Juraj Njavro" Vukovar, 32000 Vukovar, Croatia.

ORCID-Profile: Ema Schönberger, Luka Švitek, Barbara Grubišić, Tara Cvijić Perić, Romana Marušić, Nika Vlahović Vlašić, Tomislav Kizivat, Silvija Canecki Varžić, Lorna Stemberger Marić, Ines Bilić Ćurčić

Förderung

  • Faculty of Medicine Osijek, located at J. Huttlera 4, 31000 Osijek, Croatia

Zitieren

APA

Schönberger, E., Švitek, L., Grubišić, B., Cvijić Perić, T., Marušić, R., Vlahović Vlašić, N., Kizivat, T., Canecki Varžić, S., Stemberger Marić, L., & Bilić Ćurčić, I. (2025). Beyond Tumor Immunity: The Disruption of Endocrine and Infectious Homeostasis by Immune Checkpoint Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311619

Vancouver

Schönberger E, Švitek L, Grubišić B, Cvijić Perić T, Marušić R, Vlahović Vlašić N, et al. Beyond Tumor Immunity: The Disruption of Endocrine and Infectious Homeostasis by Immune Checkpoint Inhibitors. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311619

BibTeX
@article{Schnberger2025,
  author = {Schönberger, Ema and Švitek, Luka and Grubišić, Barbara and Cvijić Perić, Tara and Marušić, Romana and Vlahović Vlašić, Nika and Kizivat, Tomislav and Canecki Varžić, Silvija and Stemberger Marić, Lorna and Bilić Ćurčić, Ines},
  title = {Beyond Tumor Immunity: The Disruption of Endocrine and Infectious Homeostasis by Immune Checkpoint Inhibitors},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262311619}
}
Kostenlos starten →